Healthtech funding in Q2 2020
European Healthtech startup funding raised during Q2 2020.
In Q2 2020, 93 European Healthtech companies closed 94 funding rounds and raised €1.5B in equity funding (excluding debt and grants), up 86.2% versus Q2 2019. UK led by capital raised, and Cathay Innovation was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.5B
+86.2% vs Q2 2019 · excl. debt & grants
Funding rounds
94
-10.5% vs Q2 2019
Companies
93
Top country
UK
Rank among sectors
#2
14.5% of sector funding
Top-10 round share
54.3%
of disclosed capital
Rounds ≥ €100M
2
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q2 2020 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Apr | €533M | 39 |
| May | €412M | 35 |
| Jun | €612M | 20 |
Top countries
by € raisedHealthtech — top countries by capital, Q2 2020 — interactive chart.
Data table
| Healthtech — top countries by capital, Q2 2020 | |
|---|---|
| UK | €470M |
| Germany | €405M |
| France | €172M |
| Sweden | €102M |
| Israel | €82M |
| Switzerland | €70M |
| United States | €62M |
| Belgium | €51M |
Stage mix
by € raisedHealthtech — stage mix, Q2 2020 — interactive chart.
Data table
| Healthtech — stage mix, Q2 2020 | |
|---|---|
| Other | €379M |
| Early VC | €329M |
| Series B | €258M |
| Series A | €222M |
| Series C | €218M |
| Growth/Late | €51M |
| Series D+ | €46M |
| Seed | €36M |
| Grant | €19M |
Exits & M&A
5 Acquisition · 1 Buyout8 exits · €12M disclosed.
| Inui Health | Acquisition | Jun 2020 | €8.0M |
| 2CSI | Acquisition | Apr 2020 | €2.1M |
| ApiFix | Acquisition | Apr 2020 | €1.8M |
Top deals
largest disclosed rounds in Q2 2020| Company | Stage | Date | Amount |
|---|---|---|---|
| CureVac | Early VC | Jun 2020 | €300M |
| Oxford Nanopore Technologies | Other | Apr 2020 | €124M |
| Compass Pathways | Series B | Apr 2020 | €74M |
| Verve Therapeutics | Series A | Jun 2020 | €56M |
| Exscientia | Series C | May 2020 | €55M |
| Oxford Nanopore Technologies | Other | May 2020 | €54M |
| Avacta Group | Growth/Late | Apr 2020 | €51M |
| Enterome | Series D+ | Jun 2020 | €46M |
| Doktor.se | Series C | May 2020 | €45M |
| Robocath | Series C | Apr 2020 | €40M |
| Polares Medical | Other | Jun 2020 | €35M |
| eTheRNA | Series B | Jun 2020 | €34M |
| Perspectum | Other | Apr 2020 | €33M |
| PlusDental | Series C | May 2020 | €32M |
| Ona Therapeutics | Series A | Jun 2020 | €30M |
Top investors
most active in Q2 2020, by deal count- Cathay Innovation2 deals
- High-Tech Gründerfonds (HTGF)2 deals
- OurCrowd2 deals
- Sofinnova Partners2 deals
- Venture Kick2 deals
- 4FO Ventures1 deals
- Add Health Media1 deals
- Almi Invest1 deals
- Alta Life Sciences1 deals
- Amadeus Capital Partners1 deals